UniProt ID | SNUT2_HUMAN | |
---|---|---|
UniProt AC | Q53GS9 | |
Protein Name | U4/U6.U5 tri-snRNP-associated protein 2 | |
Gene Name | USP39 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 565 | |
Subcellular Localization | Nucleus . | |
Protein Description | Plays a role in pre-mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the spliceosome. Regulates AURKB mRNA levels, and thereby plays a role in cytokinesis and in the spindle checkpoint. Does not have ubiquitin-specific peptidase activity, but could be a competitor of ubiquitin C-terminal hydrolases (UCHs).. | |
Protein Sequence | MSGRSKRESRGSTRGKRESESRGSSGRVKRERDREREPEAASSRGSPVRVKREFEPASAREAPASVVPFVRVKREREVDEDSEPEREVRAKNGRVDSEDRRSRHCPYLDTINRSVLDFDFEKLCSISLSHINAYACLVCGKYFQGRGLKSHAYIHSVQFSHHVFLNLHTLKFYCLPDNYEIIDSSLEDITYVLKPTFTKQQIANLDKQAKLSRAYDGTTYLPGIVGLNNIKANDYANAVLQALSNVPPLRNYFLEEDNYKNIKRPPGDIMFLLVQRFGELMRKLWNPRNFKAHVSPHEMLQAVVLCSKKTFQITKQGDGVDFLSWFLNALHSALGGTKKKKKTIVTDVFQGSMRIFTKKLPHPDLPAEEKEQLLHNDEYQETMVESTFMYLTLDLPTAPLYKDEKEQLIIPQVPLFNILAKFNGITEKEYKTYKENFLKRFQLTKLPPYLIFCIKRFTKNNFFVEKNPTIVNFPITNVDLREYLSEEVQAVHKNTTYDLIANIVHDGKPSEGSYRIHVLHHGTGKWYELQDLQVTDILPQMITLSEAYIQIWKRRDNDETNQQGA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 (in isoform 2) | Phosphorylation | - | 36.26 | 30206219 | |
7 (in isoform 2) | Phosphorylation | - | 48.66 | 30206219 | |
11 (in isoform 2) | Phosphorylation | - | 42.52 | 30206219 | |
42 | Phosphorylation | EREPEAASSRGSPVR HCCHHHHHCCCCCCE | 27.84 | 23401153 | |
43 | Phosphorylation | REPEAASSRGSPVRV CCHHHHHCCCCCCEE | 35.61 | 23401153 | |
46 | Phosphorylation | EAASSRGSPVRVKRE HHHHCCCCCCEEEEE | 21.07 | 20201521 | |
51 | Sumoylation | RGSPVRVKREFEPAS CCCCCEEEEECCCCC | 35.33 | 28112733 | |
58 | Phosphorylation | KREFEPASAREAPAS EEECCCCCCCCCCCC | 38.28 | 26074081 | |
65 | Phosphorylation | SAREAPASVVPFVRV CCCCCCCCCCCEEEE | 23.69 | 20068231 | |
73 | Sumoylation | VVPFVRVKREREVDE CCCEEEEEEEECCCC | 37.67 | - | |
82 | Phosphorylation | EREVDEDSEPEREVR EECCCCCCCCHHHHH | 53.67 | 29255136 | |
97 | Phosphorylation | AKNGRVDSEDRRSRH HHCCCCCCHHHHHCC | 38.24 | 20068231 | |
102 | Phosphorylation | VDSEDRRSRHCPYLD CCCHHHHHCCCCCHH | 27.54 | 28555341 | |
207 | Ubiquitination | QQIANLDKQAKLSRA HHHCCHHHHHHHHHC | 56.15 | - | |
207 | Acetylation | QQIANLDKQAKLSRA HHHCCHHHHHHHHHC | 56.15 | 25953088 | |
210 | Ubiquitination | ANLDKQAKLSRAYDG CCHHHHHHHHHCCCC | 44.49 | - | |
259 | Phosphorylation | YFLEEDNYKNIKRPP HCCCCCCCCCCCCCC | 20.10 | - | |
260 | Ubiquitination | FLEEDNYKNIKRPPG CCCCCCCCCCCCCCC | 59.45 | - | |
283 | Ubiquitination | RFGELMRKLWNPRNF HHHHHHHHHHCCCCC | 43.84 | - | |
291 | Methylation | LWNPRNFKAHVSPHE HHCCCCCCCCCCHHH | 40.92 | 115978891 | |
308 | Ubiquitination | QAVVLCSKKTFQITK HHHHHHCCCEEEEEE | 55.63 | - | |
325 | Acetylation | DGVDFLSWFLNALHS CCHHHHHHHHHHHHH | 12.14 | 19608861 | |
343 | Phosphorylation | GTKKKKKTIVTDVFQ CCCCCCCEEEEECCC | 29.56 | 20068231 | |
346 | Phosphorylation | KKKKTIVTDVFQGSM CCCCEEEEECCCCCE | 23.69 | 20068231 | |
352 | Phosphorylation | VTDVFQGSMRIFTKK EEECCCCCEEHHCCC | 8.29 | 20068231 | |
353 | Sulfoxidation | TDVFQGSMRIFTKKL EECCCCCEEHHCCCC | 4.94 | 21406390 | |
357 | Phosphorylation | QGSMRIFTKKLPHPD CCCEEHHCCCCCCCC | 25.54 | 20068231 | |
426 | Phosphorylation | LAKFNGITEKEYKTY HHHHCCCCHHHHHHH | 42.26 | 28509920 | |
428 | Acetylation | KFNGITEKEYKTYKE HHCCCCHHHHHHHHH | 58.66 | 23749302 | |
428 | Ubiquitination | KFNGITEKEYKTYKE HHCCCCHHHHHHHHH | 58.66 | 19608861 | |
430 | Phosphorylation | NGITEKEYKTYKENF CCCCHHHHHHHHHHH | 21.50 | 28509920 | |
432 | Phosphorylation | ITEKEYKTYKENFLK CCHHHHHHHHHHHHH | 38.63 | 28509920 | |
432 | O-linked_Glycosylation | ITEKEYKTYKENFLK CCHHHHHHHHHHHHH | 38.63 | 30379171 | |
433 | Phosphorylation | TEKEYKTYKENFLKR CHHHHHHHHHHHHHH | 16.50 | 28509920 | |
434 | 2-Hydroxyisobutyrylation | EKEYKTYKENFLKRF HHHHHHHHHHHHHHH | 51.95 | - | |
434 | Acetylation | EKEYKTYKENFLKRF HHHHHHHHHHHHHHH | 51.95 | 26822725 | |
434 | Ubiquitination | EKEYKTYKENFLKRF HHHHHHHHHHHHHHH | 51.95 | - | |
439 | Acetylation | TYKENFLKRFQLTKL HHHHHHHHHHCCCCC | 47.21 | 25953088 | |
445 | Ubiquitination | LKRFQLTKLPPYLIF HHHHCCCCCCCCHHE | 68.53 | - | |
455 | Acetylation | PYLIFCIKRFTKNNF CCHHEEEEECCCCCC | 42.51 | 26051181 | |
459 | Acetylation | FCIKRFTKNNFFVEK EEEEECCCCCCEECC | 47.37 | 25953088 | |
466 | Acetylation | KNNFFVEKNPTIVNF CCCCEECCCCEEEEC | 64.03 | 26051181 | |
466 | Ubiquitination | KNNFFVEKNPTIVNF CCCCEECCCCEEEEC | 64.03 | - | |
481 | Methylation | PITNVDLREYLSEEV CCCCCCHHHHHHHHH | 26.50 | 115919629 | |
508 | Ubiquitination | ANIVHDGKPSEGSYR EEEEECCCCCCCEEE | 51.97 | - | |
510 | Phosphorylation | IVHDGKPSEGSYRIH EEECCCCCCCEEEEE | 59.06 | 24300666 | |
513 | Phosphorylation | DGKPSEGSYRIHVLH CCCCCCCEEEEEEEE | 13.74 | 24300666 | |
514 | Phosphorylation | GKPSEGSYRIHVLHH CCCCCCEEEEEEEEC | 25.17 | 24300666 | |
523 | Phosphorylation | IHVLHHGTGKWYELQ EEEEECCCCCEEEEC | 31.09 | 24300666 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SNUT2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SNUT2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SNUT2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-428, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-42; SER-46 AND SER-82,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-82, AND MASSSPECTROMETRY. |